lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer)..may 18, 2018..

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..

the lethal vaping device was identified as a smok-e mountain brand, which is manufactured in the philippines, according to the local tampa bay times newspaper. .